مختصر البحث:
Human samples of human Coxsakievirus, Adenovirus and COVID-19 virus were collected during October, 1st, 2021
to 8 of December 2021. Human Coxsakievirus, Adenovirus and COVID-19 virus was including (1 month, 1-15 years).
The RT-PCR method was detec…
Human samples of human Coxsakievirus, Adenovirus and COVID-19 virus were collected during October, 1st, 2021
to 8 of December 2021. Human Coxsakievirus, Adenovirus and COVID-19 virus was including (1 month, 1-15 years).
The RT-PCR method was detected of all samples, the results showed sixty eight (68%) while thirty two (32%) negative
cases, sixty four (64%) while thirty six (36%) negative cases and twenty five (25%) while seventy five (75%) negative
cases. The Population groups studied samples subject groups were distribution into (6) groups including (1 month,
1-15, 16-31 and 32-47 and 48-63 and 64-79 and 80-95) year, changed age too gender. Our study also showed that
the fourth groups (48-63) years is the largest percentage (41.18) of coxsakievirus, adenovirus (43.75) and COVID-19
virus (44) in compare of aged groups then [1 month, 1-15(4.41%) coxsakievirus, (4.68%) Adenovirus, (0) COVID-19;
16-31 (7.35%) Coxsakievirus, (9.37%) Adenovirus, (12%) COVID-19 virus; 32-47 (22.05%) Coxsakievirus, (17.18%)
Adenovirus, (20%) COVID-19 virus; 64-79 (25%) Coxsakievirus, (25%) Adenovirus, (20%) COVID-19 virus; 80-95
(0) for Coxsakievirus and Adenovirus, (4%) COVID-19 virus years. The samples were isolated from the hospitals
including (Al-Sadr, AL Hakeem, AL Sajjad), the first study in Iraq to diagnose of human Coxsakievirus, Adenovirus,
COVID-19 virus with myocarditis.